A new study in rats suggests that xylazine, the active ingredient in a non-opioid veterinary tranquilizer not approved for human use, can worsen the life-threatening effects of opioids.
Jun 20, 2023
0
26
Oxidative stress—characterized by elevated levels of unstable molecules called reactive oxygen species—is associated with neurodegeneration and cardiovascular disease. However, until recently it has not been possible ...
Jun 14, 2023
0
75
A new virtual ward to safely treat atrial fibrillation patients could prevent thousands of hospital admissions per year, easing NHS pressure, according to new research from the University of Leicester presented at the British ...
Jun 6, 2023
0
1
The low blood oxygen levels of obstructive sleep apnea (OSA) cause widespread changes in gene activity throughout the day, according to a new study in the open-access journal PLOS Biology by David Smith of Cincinnati Children's ...
May 30, 2023
0
31
Obstructive sleep apnea (OSA) tests may underestimate the severity of OSA in Black patients, according to research published at the ATS 2023 International Conference.
May 23, 2023
0
5
A study conducted by UMC Utrecht during the pandemic showed that patients can easily perform oxygen measurements themselves at home, they felt safe doing so and the number of GP or hospital visits did not increase. The researchers ...
May 10, 2023
0
7
A unique target for molecular imaging combined with the power of near-infrared fluorescent light to identify blood clots could provide a potential new approach for early and accurate diagnosis of blood clots.
May 4, 2023
0
13
In the spiraling cycle that can lead to vision loss in premature newborns, Medical College of Georgia scientists have found a new target and drug that together appear to stop the destruction in its tracks.
Apr 20, 2023
0
74
In September 2020, Frantz Dickerson caught COVID-19.
Apr 19, 2023
0
2
Patients with relapsed or refractory multiple myeloma who were treated with the two highest doses of REGN5459, a bispecific antibody targeting BCMA and CD3, experienced a 90.5% overall response rate, according to results ...
Apr 17, 2023
0
11
